Trials / Completed
CompletedNCT01148368
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare and evaluate the pharmacokinetic characteristics and the safety of fimasartan in renal impairment patients and healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fimasartan | single administration of fimasartan 120mg |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2010-07-01
- Completion
- 2011-07-01
- First posted
- 2010-06-22
- Last updated
- 2012-01-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01148368. Inclusion in this directory is not an endorsement.